Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02XGS
|
||||
| Former ID |
DNC010440
|
||||
| Drug Name |
2-fluorophenyl 4-(hexyloxy)phenylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C19H22FNO3
|
||||
| Canonical SMILES |
CCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F
|
||||
| InChI |
1S/C19H22FNO3/c1-2-3-4-7-14-23-16-12-10-15(11-13-16)21-19(22)24-18-9-6-5-8-17(18)20/h5-6,8-13H,2-4,7,14H2,1H3,(H,21,22)
|
||||
| InChIKey |
ASBZIVYPMZQHBL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.